Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Thorax 2007;62:654-655; doi:10.1136/thx.2007.077594
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Detterbeck, F. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Detterbeck, F. C
Topic Collections
Right arrowRelevant Article

EDITORIAL

Staging of NSCLC

Evolution and science, progress and change

Frank C Detterbeck

Correspondence to:
Correspondence to:
Dr Frank C Detterbeck
Thoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062, USA; frank.detterbeck@yale.edu


Positron emission tomography in staging of intrathoracic lymph nodes in non-small cell lung cancer

The first 150 words of the full text of this article appear below.

Staging of non-small cell lung cancer (NSCLC) has undergone a significant evolution, from plain chest radiographs to anatomical imaging, invasive techniques and, most recently, metabolic imaging using positron emission tomography (PET) scans. Even the literature regarding PET imaging has undergone significant evolution. Initial reports were characterised by compelling yet anecdotal images. This was followed by approximately 10 years of studies showing that mediastinal staging by PET was superior to computed tomography (CT) which, of course, was not surprising because CT had already been shown to be notoriously misleading in many situations. Eventually authors began addressing the clinically more relevant question of whether PET can replace invasive mediastinal staging. The article by Tournoy and colleagues1 in this issue of Thorax illustrates how far we have come (see page 696). Not only does this study use the most sophisticated technology—an integrated PET/CT scanner—but, more importantly, the authors . . . [Full text of this article]


Relevant Article

Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study
K G Tournoy, S Maddens, R Gosselin, G Van Maele, J P van Meerbeeck, and A Kelles
Thorax 2007 62: 696-701. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society